Ident. | Authors (with country if any) | Title |
---|
002D47 (2004) |
Z. K. Wszolek [États-Unis] ; R. F. Pfeiffer [États-Unis] ; Y. Tsuboi [États-Unis] ; R. J. Uitti [États-Unis] ; R. D. Mccomb [États-Unis] ; A. J. Stoessl [Canada] ; A. J. Strongosky [États-Unis] ; A. Zimprich [Allemagne] ; B. Müller-Myhsok [Allemagne] ; M. J. Farrer [États-Unis] ; T. Gasser [Allemagne] ; D. B. Calne [Canada] ; D. W. Dickson [États-Unis] | Autosomal dominant parkinsonism associated with variable synuclein and tau pathology |
003503 (2000) |
R. Horowski [Allemagne] ; L. Horowski [Allemagne] ; S. M. Calne [Canada] ; D. B. Calne [Canada] | From Wilhelm von Humboldt to Hitler—are prominent people more prone to have Parkinson's disease? |
003567 (2000) |
B. J. Snow [Canada] ; F. J. G. Vingerhoets [Canada] ; J. W. Langston [États-Unis] ; J. W. Tetrud [États-Unis] ; V. Sossi [Canada] ; D. B. Calne [Canada] | Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism |
003585 (2000) |
R. De La Fuente-Fernandez [Canada] ; P. K. Pal [Canada] ; F. J. G. Vingerhoets [Canada] ; A. Kishore [Canada] ; M. Schulzer [Canada] ; E. K. Mak [Canada] ; T. J. Ruth [Canada] ; B. J. Snow [Canada] ; D. B. Calne [Canada] ; A. J. Stoessl [Canada] | Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations |
003593 (2000) |
P. K. Pal [Canada] ; D. B. Calne [Canada] ; S. Calne [Canada] ; J. K. C. Tsui [Canada] | Botulinum toxin A as treatment for drooling saliva in PD |
003718 (1999) |
A. Samii [Canada] ; I. M. Turnbull [Canada] ; A. Kishore [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; S. Yardley [Canada] ; D. B. Calne [Canada] | Reassessment of unilateral pallidotomy in Parkinson's disease |
003791 (1999) |
C. R. Honey [Canada] ; A. J. Stoessl [Canada] ; J. K. C. Tsui [Canada] ; M. Schulzer [Canada] ; D. B. Calne [Canada] | Unilateral pallidotomy for reduction of parkinsonian pain |
003810 (1999) |
A. Samii [Canada] ; K. Markopoulou [États-Unis] ; Z. K. Wszolek [États-Unis] ; V. Sossi [Canada] ; T. Dobko [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada] ; A. J. Stoessl [Canada] | PET studies of parkinsonism associated with mutation in the α-synuclein gene |
003811 (1999) |
J. K. C. Tsui [Canada] ; D. B. Calne [Canada] ; YUE WANG [Canada] ; M. Schulzer [Canada] ; S. A. Marion [Canada] | Occupational risk factors in Parkinson's disease |
003A31 (1998) |
C.-C. Huang [Taïwan] ; N.-S. Chu [Taïwan] ; C.-S. Lu [Taïwan] ; R.-S. Chen [Taïwan] ; D. B. Calne [Canada] | Long-term progression in chronic manganism : Ten years of follow-up |
003A37 (1998) |
M. D. Muenter [États-Unis] ; L. S. Forno [États-Unis] ; O. Hornykiewicz [Autriche] ; S. J. Kish [Canada] ; D. M. Maraganore [États-Unis] ; R. J. Caselli [États-Unis] ; H. Okazaki [États-Unis] ; F. M. Jr Howard [États-Unis] ; B. J. Snow [Australie] ; D. B. Calne [Canada] | Hereditary form of parkinsonism-dementia |
003A57 (1998) |
T. Gasser [Allemagne] ; B. Müller-Myhsok [Allemagne] ; Z. K. Wszolek [États-Unis] ; R. Oehlmann [Allemagne] ; D. B. Calne [Canada] ; V. Bonifati [Italie] ; B. Bereznai [Allemagne] ; E. Fabrizio [Italie] ; P. Vieregge [Allemagne] ; R. D. Horstmann [Allemagne] | A susceptibility locus for Parkinson's disease maps to chromosome 2p13 |
003B22 (1997) |
Z. K. Wszolek [États-Unis] ; P. Vieregge [Allemagne] ; R. J. Uitti [Canada] ; T. Gasser [Canada] ; O. Yasuhara [Canada] ; P. Mcgeer [Canada] ; K. Berry [États-Unis] ; D. B. Calne [Allemagne] ; F. J. G. Vingerhoets [Allemagne] ; C. Klein [Allemagne] ; R. F. Pfeiffer [États-Unis] | German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia — Longitudinal observations |
003C59 (1997) |
A. Kishore [Canada] ; I. M. Turnbull [Canada] ; B. J. Snow [Canada] ; R. De La Fuente-Fernandez [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; S. Yardley [Canada] ; D. B. Calne [Canada] | Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease: Six-month follow-up with additional 1-year observations |
003C78 (1997) |
R. J. Uitti [Canada] ; H. Shinotoh [Canada] ; M. Hayward [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada] | "Familial Parkinson's disease": A case-control study of families |
004008 (1995) |
Konstantine K. Duarte [Espagne] ; L. E. Clavería ; J. De Pedro-Cuesta [Espagne, Suède] ; A. P. Sempere ; F. Coria ; D. B. Calne [Canada] | Screening Parkinson's disease: A validated questionnaire of high specificity and sensitivity |
004081 (1995) |
H. Shinotoh [Canada] ; D. B. Calne | The use of PET in Parkinson's disease |
004091 (1995) |
C. S. Lee [Canada] ; M. Schulzer ; E. Mak ; J. P. Hammerstad ; S. Calne ; D. B. Calne | Patterns of asymmetry do not change over the course of idiopathic parkinsonism : implications for pathogenesis |
004187 (1994) |
M. Schulzer [Canada] ; C. S. Lee [Canada] ; E. K. Mak [Canada] ; F. J. G. Vingerhoets [Canada] ; D. B. Calne [Canada] | A mathematical model of pathogenesis in idiopathic parkinsonism |
004207 (1994) |
J. P. Hammerstad [Canada] ; K. Elliott [Canada] ; E. Mak [Canada] ; M. Schulzer [Canada] ; S. Calne [Canada] ; D. B. Calne [Canada] | Tendon jerks in Parkinson's disease |
004243 (1994) |
F. J. G. Vingerhoets [Canada] ; F. J. G. Snow [Canada] ; C. S. Lee [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada] | Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism |
004246 (1994) |
Ivar Gasser [États-Unis, Allemagne] ; Z. K. Wszolek [États-Unis] ; J. Trofatter [États-Unis] ; L. Ozelius [États-Unis] ; R. J. Uitti [Canada] ; C. S. Lee [Canada] ; J. Gusella [États-Unis] ; R. F. Pfeiffer [États-Unis] ; D. B. Calne [Canada] ; X. O. Breakefield [États-Unis] | Genetic linkage studies in autosomal dominant parkinsonism: Evaluation of seven candidate genes |
004298 (1994) |
D. B. Calne [Canada] ; N.-S. Chu ; C.-C. Huang ; C.-S. Lu ; W. Olanow | Manganism and idiopathic parkinsonism : similarities and differences |
004300 (1994) |
D. B. Calne [Canada] | Is idiopathic parkinsonism the consequence of an event or a process ? |
004352 (1993) |
H. Takahashi [Canada] ; Bj Snow [Canada] ; M. H. Bhatt [Canada] ; R. Peppard [Canada] ; A. Eisen [Canada] ; D. B. Calne [Canada] | Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning |
004383 (1993) |
Michael Schulzer [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada] | Reply |
004387 (1993) |
M. Cordes [Canada, Allemagne] ; B. J. Snow [Canada] ; S. Morrison [Canada] ; V. Sossi [Canada] ; T. J. Ruth [Canada] ; D. B. Calne [Canada] | Parametric imaging of the rate constant Ki using [18Fluoro]- l -dopa positron emission tomography in progressive supranuclear palsy |
004401 (1993) |
B. J. Snow [Canada] ; I. Tooyama [Canada, Japon] ; I. Mcgeer [Canada] ; T. Yamada [Canada] ; D. B. Calne [Canada] ; H. Takahashi [Canada] ; H. Kimura [Japon] | Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levels |
004405 (1993) |
T. Yamada [Canada] ; D. B. Calne [Canada] ; H. Akiyama [Japon] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Further observations on Tau-positive glia in the brains with progressive supranuclear palsy |
004419 (1993) |
Janice J. Pate [Canada] ; T. Kawamata [Canada] ; T. Yamada [Canada] ; E. G. Mcgeer [Canada] ; K. A. Hewitt [Canada] ; B. J. Snow [Canada] ; T. J. Ruth [Canada] ; D. B. Calne [Canada] | Correlation of striatal fluorodopa uptake in the MPTP Monkey with dopaminergic indices |
004432 (1993) |
D. B. Calne [Canada] | Treatment of Parkinson's disease |
004439 (1993) |
R. J. Uitti [Canada] ; D. B. Calne | Pathogenesis of idiopathic parkinsonism |
004442 (1993) |
D. B. Calne [Canada] ; B. J. Snow | PET imaging in parkinsonism |
004455 (1993) |
B. D. Pate [Canada] ; T. Kawamata ; T. Yamada ; E. G. Mcgeer [Canada] ; K. A. Hewitt [Canada] ; B. J. Snow [Canada] ; T. J. Ruth [Canada] ; D. B. Calne [Canada] | Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices |
004457 (1993) |
H. Takahashi [Canada] ; B. J. Snow [Canada] ; T. G. Nygaard ; D. B. Calne [Canada] | Clinical heterogeneity of dopa-responsive dystonia : PET observations |
004549 (1992) |
James W. Schulzer [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada] | The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic |
004555 (1992) |
D B Wszolek [États-Unis, Canada] ; R. F. Pfeiffer [États-Unis] ; M. H. Bhatt [Canada] ; R. L. Schelper [États-Unis] ; M. Cordes [Canada] ; B. J. Snow [Canada] ; R. L. Rodnitzky [États-Unis] ; E. Ch Wolters [Pays-Bas] ; F. Arwert [Pays-Bas] ; D. B. Calne [Canada] | Rapidly progressive autosomal dominant parkinsonism and dementia with pallido‐ponto‐nigral degeneration |
004624 (1992) |
D. B. Calne [Canada] | The nature of Pakinson's disease |
004625 (1992) |
D. B. Calne [Canada] | The free radical hypothesis in idiopathic Parkinsonism : evidence against it |
004628 (1992) |
M. Schulzer [Canada] ; E. Mark ; D. B. Calne | The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic |
004655 (1992) |
D. B. Calne [Canada] ; B. J. Snow ; C. Lee | Criteria for diagnosing Parkinson's disease |
004657 (1992) |
R. F. Peppard [Canada] ; R. Wayne Martin [Canada] ; G. D. Carr ; E. Grochowski ; M. Schulzer [Canada] ; M. Guttman [Canada] ; P. L. Mcgeer ; A. G. Phillips ; J. K. C. Tsui [Canada] ; D. B. Calne [Canada] | Cerebral glucose metabolism in Parkinson's disease with and without dementia |
004664 (1992) |
M. Cordes [Canada] ; B. J. Snow ; H. Takahashi ; P. Schofield ; S. Cooper ; V. Sossi ; S. Morrison ; D. B. Calne | L-18F-DOPA-PET bei Parkinson-Plus-Syndromen zum Nachweis einer gestörten präsynaptischen dopaminergen Funktion |
004819 (1991) |
D. B. Calne [Canada] | Neurotoxins and degeneration in the central nervous system |
004829 (1991) |
D. B. Calne ; M. J. Zigmond | Compensatory mechanisms in degenerative neurologic diseases : insights from Parkinsonism |
004962 (1990) |
R. F. Peppard ; W. R. W. Martin [Canada] ; C. M. Clark ; G. D. Carr ; P. L. Mcgeer ; D. B. Calne | Cortical glucose metabolism in parkinson's and alzheimer's disease |
004987 (1990) |
M. H. Bhatt ; B. J. Snow ; W. R. W. Martin ; S. Cooper ; D. B. Calne | Positron emission tomography in Shy-Drager syndrome |
004993 (1990) |
M. Guttman ; H. C. Fibiger ; A. Jakubovic ; D. B. Calne | Intracarotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism |
004A02 (1990) |
J. K. C. Tsui ; R. F. Peppard ; K. C. Petruk ; G. Allen ; R. S. Burns ; D. B. Calne | Decreased efficay of levodopa with carbidopa in parkinsonian patients after adrenal-to-caudate implants |
004A04 (1990) |
E. C. Wolters ; T. A. Hurwitz ; E. Mak ; P. Teal ; F. R. Peppard ; R. Remick ; S. Calne ; D. B. Calne | Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis |
004A94 (1989) |
Richard L. Martin [Canada] ; M. R. Palmer [Canada] ; C. S. Patlak [États-Unis] ; D. B. Calne | Nigrostriatal function in humans studied with positron emission tomography |